Vincent Jung-Fai Wong - 21 Dec 2021 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
21 Dec 2021
Net transactions value
$0
Form type
4
Filing time
23 Dec 2021, 16:29:25 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +122,054 $0.000000 122,054 21 Dec 2021 Common Stock 122,054 $3.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a three year period such that the option is fully vested on December 21, 2024, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).